Aspirin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
Condition:   AERD - Aspirin Exacerbated Respiratory Disease Interventions:   Drug: Aspirin 300 Mg Oral Tablet;   Drug: Placebo Sponsor:   Lucyna Mastalerz Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials

Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Conditions:   Atherosclerosis of Artery;   Coronary Artery Disease;   Peripheral Arterial Disease;   Carotid Stenosis Intervention:   Drug: Rivaroxaban 2.5mg Sponsors:   Asan Medical Center;   Bayer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials

Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
Condition:   AERD - Aspirin Exacerbated Respiratory Disease Interventions:   Drug: Aspirin 300 Mg Oral Tablet;   Drug: Placebo Sponsor:   Lucyna Mastalerz Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials

Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Conditions:   Atherosclerosis of Artery;   Coronary Artery Disease;   Peripheral Arterial Disease;   Carotid Stenosis Intervention:   Drug: Rivaroxaban 2.5mg Sponsors:   Asan Medical Center;   Bayer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials

Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
Condition:   AERD - Aspirin Exacerbated Respiratory Disease Interventions:   Drug: Aspirin 300 Mg Oral Tablet;   Drug: Placebo Sponsor:   Lucyna Mastalerz Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials

Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Conditions:   Atherosclerosis of Artery;   Coronary Artery Disease;   Peripheral Arterial Disease;   Carotid Stenosis Intervention:   Drug: Rivaroxaban 2.5mg Sponsors:   Asan Medical Center;   Bayer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials

Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
Condition:   AERD - Aspirin Exacerbated Respiratory Disease Interventions:   Drug: Aspirin 300 Mg Oral Tablet;   Drug: Placebo Sponsor:   Lucyna Mastalerz Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials

Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Conditions:   Atherosclerosis of Artery;   Coronary Artery Disease;   Peripheral Arterial Disease;   Carotid Stenosis Intervention:   Drug: Rivaroxaban 2.5mg Sponsors:   Asan Medical Center;   Bayer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials

Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease
Condition:   AERD - Aspirin Exacerbated Respiratory Disease Interventions:   Drug: Aspirin 300 Mg Oral Tablet;   Drug: Placebo Sponsor:   Lucyna Mastalerz Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials